Syed Maqsood, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Turnpike, Nassau Health Care Corp, East Meadows, NY 11554 Phone: 516-572-6637 |
News Archive
Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet.
Since August 2014, aflibercept (trade name Eylea) has been available also for patients with visual impairment due to diabetic macular oedema (DMO). The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy.
Compassion & Choices reports the District of Columbia is poised to become the seventh jurisdiction in the U.S. where medical aid in dying is authorized for terminally ill residents after the D.C. Council passed the D.C. Death with Dignity Act by a veto-proof 11-2 margin.
Biocept, Inc., an emerging leader in rare cell capture, announced today that the U.S. Patent and Trademark Office has issued a patent for Biocept's cell separation technology using a microfluidic device. U.S. patent #7,695,956 entitled "Device for Cell Separation and Analysis and Method of Using" protects Biocept's microflow device to isolate cells from a bodily fluid using a flow path where straight-line flow is interrupted by transverse posts arranged in a random pattern.
Consuming an alcoholic beverage may make men more responsive to the smiles of others in their social group, according to new research in Clinical Psychological Science, a journal of the Association for Psychological Science. The findings suggest that, for men, alcohol increases sensitivity to rewarding social behaviors like smiling, and may shed light on risk factors that contribute to problem drinking among men.
› Verified 1 days ago